BioCentury
ARTICLE | Clinical News

CancerVax resumes Phase III enrollment

April 15, 2003 7:00 AM UTC

CancerVax (Carlsbad, Calif.) said the FDA released a partial clinical hold on enrollment in the company's international Phase III trials of Canvaxin for post-surgical treatment of patients with stage ...